Detalhe da pesquisa
1.
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program.
Mol Cancer
; 21(1): 175, 2022 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057593
2.
Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry.
Cytometry A
; 85(12): 1020-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25155056
3.
Targeting the Hedgehog Pathway in Rhabdomyosarcoma.
Cancers (Basel)
; 15(3)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765685
4.
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon.
Cancers (Basel)
; 15(6)2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980521
5.
Notch, wnt, and hedgehog pathways in rhabdomyosarcoma: from single pathways to an integrated network.
Sarcoma
; 2012: 695603, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22550422
6.
Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro.
Cancers (Basel)
; 13(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638328
7.
CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models.
Cancers (Basel)
; 12(7)2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32708733
8.
The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis.
Cell Death Dis
; 11(9): 773, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943619
9.
Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer.
Front Oncol
; 9: 1173, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31781490
10.
[Novel micro RNA-based therapies for the treatment of neuroblastoma]. / Nuevas estrategias terapéuticas para el neuroblastoma basadas en el uso de microRNAs.
An Pediatr (Barc)
; 85(2): 109.e1-109.e6, 2016 Aug.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26323526
11.
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.
Clin Transl Med
; 11(10): e533, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709738
12.
Notch pathway inhibition significantly reduces rhabdomyosarcoma invasiveness and mobility in vitro.
Clin Cancer Res
; 17(3): 505-13, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21177409
13.
Characterisation of novel splicing variants of the tyrosine hydroxylase C-terminal domain in human neuroblastic tumours.
Biol Chem
; 388(4): 419-26, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17391063